Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-04-08 @ 10:31 AM
Study NCT ID:
NCT00576251
Status:
COMPLETED
Last Update Posted:
2010-03-02
First Post:
2007-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
Sponsor:
Alcon Research
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10
Start Date Type:
None
Primary Completion Date:
2008-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-03
Completion Date Type:
None
First Submit Date:
2007-12-17
First Submit QC Date:
None
Study First Post Date:
2007-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-09-25
Results First Submit QC Date:
None
Results First Post Date:
2010-01-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-02-23
Last Update Post Date:
2010-03-02
Last Update Post Date Type:
ESTIMATED